Medical disclaimer: This article is for educational purposes only and is not a substitute for medical advice. Vyvanse (lisdexamfetamine) carries an FDA boxed warning for misuse, dependence, and serious cardiovascular risks. Never stop or adjust Vyvanse without guidance from your prescribing clinician. If you are experiencing suicidal thoughts or thoughts of self-harm, call or text 988 to reach the Suicide and Crisis Lifeline immediately. For substance use support, contact SAMHSA's National Helpline at 1-800-662-4357 (free, confidential, 24/7).

People search "Vyvanse withdrawal" for several very different reasons — and the situation each person is actually in shapes what they're experiencing, how serious it is, and what the right response is. Someone who ran out of their prescription during a shortage is in a different clinical situation than someone tapering off after months at a high dose. Someone experiencing a daily late-afternoon crash is in a different situation than someone who has stopped cold turkey after long-term use.

Most Vyvanse withdrawal articles treat all of these as the same story. They're not, and conflating them leads to unnecessary panic in some situations and inadequate concern in others.

This article is organized around which situation you're actually in — because that's the information that actually helps.

Before Anything Else: Distinguishing the "Crash" From Actual Withdrawal

These two experiences get called the same thing and feel similar enough that the confusion is understandable.

The daily Vyvanse crash happens every day as the medication wears off. Vyvanse's prodrug mechanism produces a long, gradual release of dextroamphetamine through most of the day, but as blood levels decline in the late afternoon and evening, the dopamine and norepinephrine support that the medication was providing drops. What follows is often fatigue, irritability, mood changes, difficulty concentrating, and sometimes headache.

This is not withdrawal. It's the return to your unmedicated baseline as the medication clears — which is what's supposed to happen. It means the medication was doing something. It doesn't mean you're dependent on Vyvanse in a way that creates risk when stopping.

True withdrawal — the physiological response to removing a substance the body has adapted to — is different in timing, duration, and mechanism. It begins one to two days after the last dose (not the same afternoon), lasts days to weeks (not hours), and involves a qualitatively different experience than the daily crash.

If what you're experiencing happens every late afternoon when your medication wears off and resolves by morning, that's a crash. Talk to your prescriber about whether your coverage timing is optimal, or whether a small late-afternoon dose makes sense. It's not a reason to worry about stopping Vyvanse.

If what you're experiencing started a day or two after you stopped taking Vyvanse and hasn't resolved in the way a normal day's tiredness would, that's closer to what's typically meant by withdrawal, and the rest of this article is for you.

Why Vyvanse's Mechanism Shapes the Withdrawal Experience

Understanding how Vyvanse works helps explain why the withdrawal experience often differs from immediate-release amphetamine discontinuation.

Vyvanse is a prodrug — lisdexamfetamine — that requires conversion by red blood cell enzymes to release active dextroamphetamine. This conversion is rate-limited, producing a gradual, sustained release of dextroamphetamine rather than an immediate spike. The result during treatment is a longer, smoother effect than Adderall produces. The result during discontinuation is also a more gradual drop in blood levels as the medication clears.

This means the acute neurochemical "crash" of Vyvanse discontinuation is typically less abrupt than immediate-release stimulant discontinuation. The onset of withdrawal symptoms tends to be somewhat delayed — often beginning 24 to 48 hours after the last dose — and the initial intensity may be more gradual.

What remains consistent across stimulant withdrawal is the dopamine component: when a stimulant that has been augmenting dopamine availability is removed, the dopamine system takes time to return to its unassisted baseline. During that period, the brain has less dopamine available than it had during medication, and often less than it had before medication began, because the regulatory systems that govern dopamine release adapted to the medicated state.

The subjective experience of this is profound fatigue, low mood, reduced motivation, anhedonia (reduced ability to feel pleasure or interest), and often significant cognitive fog.

The Three Situations That All Get Called Vyvanse Withdrawal

Situation one: You've been taking Vyvanse as prescribed at a therapeutic dose and need to stop

Research on this specific situation provides useful context. A study examining lisdexamfetamine discontinuation after 26 weeks at recommended therapeutic doses for binge eating disorder found that stopping was not associated with clinically significant withdrawal symptoms in most participants. This doesn't mean no one experiences any discontinuation effects, but it sets a baseline: people taking Vyvanse therapeutically, at prescribed doses, for ADHD or BED tend to have milder discontinuation experiences than the most dramatic withdrawal accounts would suggest.

The symptoms that typically occur in this situation are real but manageable: several days of fatigue, low mood, and reduced ability to concentrate — which is partly withdrawal and partly the return of the underlying ADHD that was being treated. The ADHD doesn't go away when Vyvanse is discontinued; it returns to its unmedicated state. These two things can be difficult to distinguish subjectively, and knowing that both are happening helps calibrate expectations.

What to do: If you're stopping because you want to try a different medication, your prescriber should manage the transition — ideally without a significant gap, and with a plan to bridge symptoms. If you're stopping for other reasons (shortage, pregnancy, personal decision), contact your prescriber before stopping or as soon as possible after. Tapering even from therapeutic doses — reducing by 10-20mg steps over one to two weeks — makes the transition easier than stopping abruptly.

Situation two: You've been taking higher doses, for longer periods, with more frequent use

This is where the risk of clinically significant withdrawal is highest. At higher doses than therapeutic ranges, or with patterns of use that involve taking more than prescribed, the brain's dopamine system adapts more substantially. When the medication is removed, the adjustment back to baseline is longer and more symptomatic.

Symptoms in this situation are more intense versions of the same cluster: severe fatigue that interferes with daily functioning, depression that can be clinically significant rather than mild low mood, anxiety, intense craving for the medication, sleep disturbances, and appetite changes. The timeline extends — most acute symptoms peak in the first week but emotional symptoms including depression and anhedonia can persist for two to four weeks, and in some cases longer.

The critical safety concern in this situation is depression. Stimulant withdrawal produces a neurochemical state of dopamine and norepinephrine deficiency. For people who have been using at higher doses, the depletion can be severe enough to produce depression that warrants clinical attention in its own right — not just "I feel sad," but the inability to feel anything rewarding, persistent hopelessness, and in serious cases, thoughts of self-harm.

If you're in this situation and experiencing depression that feels severe, or if you have any thoughts of harming yourself: reach out immediately. Call or text 988 to reach the Suicide and Crisis Lifeline at any time. This is one of the situations where mental health support during withdrawal isn't optional.

What to do: Medical supervision during discontinuation is essential in this situation, not optional. If you've been using Vyvanse at doses significantly above what was prescribed, or have developed dependence patterns, telling your prescriber honestly is the right step — not because disclosure is a legal risk (your doctor is not a mandatory reporter for substance use), but because you can't get safe, managed help with withdrawal without your prescriber knowing the real picture. If your regular prescriber isn't the right person to talk to, SAMHSA's National Helpline (1-800-662-4357) can help you find appropriate support.

Situation three: You ran out and can't fill your prescription

The ADHD medication shortage has left many people unable to fill valid prescriptions, which produces an involuntary version of stimulant discontinuation that's neither planned nor supervised. This is a different situation from either of the above, and the practical response is different.

If your Vyvanse prescription can't be filled due to shortage: contact your prescriber immediately, describe the situation, and ask specifically what bridge options are available. Your prescriber may be able to prescribe a different stimulant formulation that's available (lisdexamfetamine being in shortage doesn't automatically mean other stimulants are), contact specific pharmacies with stock, or provide documentation supporting a bridge prescription.

The withdrawal experience in this situation is typically milder than Situation Two because you were taking a therapeutic dose, but it's still unplanned and unmanaged — which matters for people whose underlying ADHD is significantly impairing and who now also have to navigate the depletion of stopping. Don't try to manage a shortage disruption on your own if it lasts more than a couple of days. Your prescriber needs to know.

The Return of ADHD Versus Withdrawal: How to Tell Them Apart

One of the most important and least discussed aspects of stopping Vyvanse is distinguishing between withdrawal symptoms and the return of untreated ADHD. They look similar from the inside, but the clinical meaning and appropriate response are different.

Withdrawal symptoms are neurochemical in origin. They represent the dopamine system's temporary deficiency state while it readjusts to operating without pharmacological support. They improve over time — usually within one to two weeks for most symptoms, with a possible tail of emotional symptoms lasting a bit longer. They don't require ADHD to explain them; they'd occur in anyone who discontinued the medication after a period of use.

The return of ADHD is different. It doesn't improve over time on its own. It reflects the underlying neurodevelopmental condition that was being treated, which continues to operate on its own terms once the medication is no longer managing it. Difficulty concentrating, disorganization, impulsivity, and executive dysfunction that persists weeks after the medication has cleared and the acute withdrawal period has ended is almost certainly the ADHD returning, not ongoing withdrawal.

This distinction matters practically: if you're stopping Vyvanse to see whether you still need it, give the withdrawal period about two weeks before evaluating your baseline functioning. What you experience in the first week is heavily confounded by neurochemical adjustment. What you experience after two to three weeks — when the dopamine system has substantially readjusted — is a better indicator of what functioning without treatment looks like.

What a Tapering Plan Actually Looks Like

If you're stopping Vyvanse under prescriber guidance — the right way to do it in most circumstances — the tapering process involves gradual dose reduction over time. There's no single universally correct taper, but the following principles are consistent.

Slower tapers are more comfortable. Reducing by 10 to 20mg every one to two weeks is more manageable than reducing by more, more quickly. The appropriate pace depends on how long you've been on Vyvanse and at what dose — someone who has been on 70mg for several years will generally benefit from a longer taper than someone who has been on 30mg for a few months.

Vyvanse's available dose increments (20mg, 30mg, 40mg, 50mg, 60mg, 70mg) set natural taper steps. Moving down one step at a time and staying at each step for at least one to two weeks before reducing again gives the dopamine system time to adjust at each level before the next reduction.

Some prescribers add a bridge — a small dose of an immediate-release stimulant during the tapering process — to smooth the transition, particularly at the lower dose levels where each reduction is proportionally larger relative to where you started.

Your prescriber determines the specific taper plan for your situation. Going slower than you feel you need to is rarely a problem. Going faster than your system can adjust is the situation that produces the most difficult symptoms.

Is Stopping Cold Turkey Ever Safe?

For most people on therapeutic doses: probably more manageable than the word "withdrawal" implies, but still not the preferred approach. A taper, even a brief one, is more comfortable than stopping abruptly, and your prescriber can supervise one quickly.

For people who have been at higher doses or who have developed dependence: stopping cold turkey carries real risk, particularly the depression risk described above. Supervised tapering is not just a comfort issue in this situation — it's a safety issue.

If you've already stopped cold turkey and are now experiencing significant symptoms: contact your prescriber or, if symptoms are severe, seek medical care. The most important thing is not to suffer in isolation while significant depression, severe anxiety, or thoughts of self-harm develop. Those symptoms warrant clinical attention regardless of how they were produced.

Supporting Yourself During Discontinuation

Within the period your prescriber is supervising, several evidence-adjacent self-care approaches help the nervous system readjust more smoothly:

Sleep is the highest leverage variable. The dopamine and norepinephrine systems regulate sleep and are regulated by it, and the withdrawal period is one where sleep disruption worsens every other symptom. Consistent sleep timing — same bedtime and wake time regardless of how poorly you slept — is more helpful than trying to compensate with extra sleep, which disrupts circadian regulation. Your prescriber can discuss sleep support options if severe insomnia develops.

Exercise produces the most direct neurological support during stimulant withdrawal. Aerobic exercise increases dopamine, norepinephrine, and serotonin release through mechanisms independent of external stimulants — which is exactly what the withdrawal period has depleted. Even 20 to 30 minutes of moderate aerobic exercise on most days makes a measurable difference in energy, mood, and cognitive function during discontinuation.

Eating regularly matters even when appetite is absent. Vyvanse suppresses appetite during use; withdrawal often produces the opposite — increased appetite and carbohydrate cravings as the dopamine system seeks alternative reward signals. Regular, balanced meals stabilize blood sugar and support the neurochemical environment more than either suppression or unrestricted eating.

Reducing cognitive demand for the first week is practical rather than optional for most people. The cognitive fog of stimulant withdrawal is real, and trying to maintain normal cognitive output during this period is difficult and demoralizing. If you can defer high-stakes cognitive demands for the first week, the experience is more manageable.

When to Contact Your Prescriber Before You Planned To

Withdrawal timelines are general guides, not guarantees. Some symptoms warrant earlier contact than your next scheduled appointment:

Depression that feels severe — not just "I feel low," but the absence of any ability to feel interested, motivated, or capable of positive experience — warrants immediate contact. If depression includes thoughts of self-harm or suicidal ideation, reach out immediately: 988 by call or text is available any time, and so is emergency care.

Symptoms that are worsening rather than gradually improving after the first week warrant evaluation. Withdrawal from therapeutic doses should show gradual improvement within one to two weeks. Symptoms that are getting worse beyond that window suggest something other than typical withdrawal is occurring.

Cardiovascular symptoms — chest pain, irregular or very rapid heartbeat, significant dizziness or fainting — warrant immediate medical evaluation, not a wait-and-see approach.

Frequently Asked Questions

How long does Vyvanse withdrawal last? For most people stopping from therapeutic doses, the most noticeable physical symptoms resolve within one to two weeks. Emotional symptoms including low mood and reduced motivation may persist somewhat longer. For people stopping from higher doses after extended use, the timeline extends — acute symptoms peak in the first week, with emotional and mood symptoms possibly lasting two to four weeks or longer.

Can you stop Vyvanse cold turkey? It's possible, and for people on therapeutic doses, the experience is typically manageable. A gradual taper under prescriber guidance is preferable and produces fewer and less intense symptoms. For people who have been using at higher doses, stopping abruptly carries risk of clinically significant depression and should be medically supervised.

Is it withdrawal or is my ADHD coming back? Both can be happening simultaneously. Withdrawal symptoms — fatigue, mood changes, cognitive fog — improve over about two weeks as the dopamine system readjusts. Ongoing difficulty concentrating, disorganization, and executive dysfunction that persists beyond the withdrawal period is more likely the underlying ADHD returning than ongoing withdrawal.

Why am I so depressed after stopping Vyvanse? The dopamine and norepinephrine that Vyvanse was providing are no longer pharmacologically supplemented, and the nervous system takes time to return to its natural baseline. During that period, dopamine availability is lower than during treatment and sometimes lower than the pre-medication baseline, producing a temporary neurochemical state that presents as depression. For most people on therapeutic doses, this improves within one to two weeks. If depression feels severe, contact your prescriber.

Is it safe to take Vyvanse breaks on weekends? Regular medication holidays can be useful for some people with ADHD, particularly when school-year coverage is the primary need and weekends have lower cognitive demands. The appropriate approach depends on your specific situation. Weekend breaks don't typically produce significant withdrawal in people on therapeutic doses but can produce mild mood and energy dips on days off. Discuss the plan with your prescriber rather than stopping independently.

What should I do if I ran out of Vyvanse and can't get a refill? Contact your prescriber as soon as possible. They can check availability at specific pharmacies, consider alternative stimulant formulations that may be in better supply, or discuss whether a short medication gap is manageable given your specific situation. Don't try to manage a prescription gap on your own for more than a day or two without your prescriber's input.

Can Vyvanse withdrawal cause suicidal thoughts? In severe cases, particularly associated with higher-dose use and significant dopamine depletion, yes. If you experience thoughts of self-harm or suicide after stopping Vyvanse, call or text 988 immediately. This is one of the situations where those resources are exactly appropriate.

If you're considering stopping Vyvanse, switching medications, or managing a disruption in access, a consultation with a licensed clinician is the right starting point — both to ensure the process is as comfortable as possible and to discuss what comes next. [Book an appointment] to speak with a provider who can create a specific plan for your situation.